Home › NCT07029256

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder
* Prior abdominal imaging

Exclusion Criteria:

* History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)

About the study

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

What is being tested

• Non-Interventional Study (other)

Sponsor: Mayo Clinic · Participants: 100 · Started: Jul 26, 2024

Contact the study team

• Hosanna Yeadon, BA · Phone: 507-538-5019
• Clinical Trials Referral Office · Phone: 855-776-0015

Official record on ClinicalTrials.gov — NCT07029256

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.